Purpose: Many inner ear disorders, including M áeni àere's disease, are believed to be based on endolymphatic hydrops. We evaluated a newly proposed method for semi-quantiˆcation of endolymphatic size in patients with suspected endolymphatic hydrops that uses 2 kinds of processed magnetic resonance (MR) images.
Introduction
Endolymphatic hydrops is a pathologic anatomicalˆnding in which enlarged endolymphatic volume distends the structures bounding the endolymphatic space. 1 It has long been considered the pathologic basis for M áeni àere's disease, 2 an inner ear disorder characterized by spontaneous attacks of vertigo, ‰uctuating low frequency hearing loss, aural fullness, and tinnitus. Disease in some patients with inner ear symptoms that do not match the diagnostic guideline of M áeni àere's disease is also believed to be based on endolymphatic hydrops. [3] [4] [5] [6] Endolymphatic hydrops wasˆrst visualized in patients with M áeni àere's disease by MR imaging us-ing 3-dimensional (3D) ‰uid-attenuated inversion recovery (FLAIR) obtained 24 hours after intratympanic (IT) administration of gadoliniumbased contrast material (GBCM). 7 However, this use of GBCM is oŠ-label and requires 24 hours of waiting time and puncture of the tympanic membrane. Because some patients are not willing to receive IT administration of GBCM, especially to the ear with normal or better hearing, 8 a method to detect endolymphatic hydrops by intravenous (IV) administration of GBCM was explored. Visualization of endolymphatic hydrops in patients with M áeni àere's disease was reported using heavily T 2 -weighted 3D-FLAIR (hT 2 W-3D-FLAIR) and imaging 4 hours after IV administration of single-dose GBCM (IV-SD-GBCM). 9 The image that results from 3D-FLAIR that includes hT 2 W-3D-FLAIR is called a positive perilymph image (PPI) 9, 10 because the signal of the perilymph increases after IT or IV administration of GBCM, and the signal intensities of both endolymph and surrounding bone show values near zero.
Shortening the inversion time of 3D-FLAIR after IT administration of GBCM was proposed to clarify the boundaries of the endolymphatic space and surrounding bones and rule out partial volume averaging artifact from bones. 11 Optimal shortening of the inversion time in 3D-FLAIR suppresses the signal of perilymph with GBCM distribution to give high signal to endolymph without GBCM distribution (positive endolymph image, PEI). 11 By adjusting inversion time, PPI and PEI based on the hT 2 W-3D-FLAIR technique could be obtained after IV-SD-GBCM in a similar manner to the acquisition of PPI and PEI after IT administration of GBCM. 10 Separate visualization of endolymph, perilymph, and bone on a single image has been reported using 3D inversion recovery sequence with``real'' reconstruction (3D-real IR) after IT administration of GBCM 12 but not after IV-SD-GBCM, probably because of the lower concentration of GBCM in perilymph. Recently, the fusion of a gray-scale inverted PEI with native gray-scale PPI, that is, subtraction of the PEI from the PPI, has been reported to yield a 3D-real IR-like image even after IV-SD-GBCM. These images, termed``HYDROPS'' (HYbriD of Reversed image Of Positive endolymph signal and native image of positive perilymph Signal), facilitate recognition of endolymphatic space by IV-SD-GBCM. However, acquisition of both PPI and PEI requires 30 minutes of scan time for processing. 13 To decrease the duration of HYDROPS imaging, an alternative processing technique was developed that subtracts heavily T 2 -weighted MR cisternography (MRC) from PPI to achieve images with similar contrast to HYDROPS images. The image resulting from this technique has been termed`H YDROPS2'' (HYbriD of Reversed image Of MR cisternography and positive Perilymph Signal by heavily T 2 -weighted 3D-FLAIR). 14 Multiplication of heavily T 2 -weighted MRC and HYDROPS images to increase the contrast-tonoise ratio (CNR) between endo-and perilymph has been reported (HYDROPS-Mi2 [HYDROPS image Multiplied with heavily T 2 -weighted MR cisternography], Image #1 in the present study). 15 Using the HYDROPS-Mi2 method, CNR increased more than 200-fold, and the background signal became quite uniform. MRC can be used to boost CNR. On HYDROPS-Mi2 images, the endolymph has negative pixel values, and the perilymph has positive pixel values. The absolute values of the endo-and perilymph are quite large due to the multiplication of MRC. Pixel values of air and bone near the labyrinth are zero on HYDROPS-Mi2. MRC can also be multiplied to boost CNR for HYDROPS2 images to generate a HYDROPS2-Mi2 image (HYDROPS2 image Multiplied with heavily T 2 -weighted MR cisternography, Image #2 in the present study). The utility of HYDROPS2-Mi2 has not been reported.
Although subjective 3-to 4-point scales have been proposed and utilized to grade endolymphatic hydrops, 16, 17 more objective and quantitative methods are desired to yield robust and reliable imaging of endolymphatic hydrops. It can be expected that the increased CNR of Images #1 and #2 allows segmentation of the endo-and perilymph by the threshold setting of pixel values and semi-quantitative measurement of endolymphatic space size.
Theˆrst purpose of this study was to evaluate interobserver variability in the semi-quantiˆcation of endolymphatic size of the cochlea and vestibule in patients with suspected endolymphatic hydrops on HYDROPS-Mi2 and HYDROPS2-Mi2 images (Images #1 and #2). The second purpose was to correlate endolymphatic size measured on the 2 kinds of generated images.
Materials and Methods

Patients
We included in this study 24 consecutive patients with symptoms of tinnitus, hearing loss, and/or vertigo (7 men, 17 women, aged 13 to 82 years) who demonstrated either symptoms attributable to M áeni àere's disease or inner ear symptoms with no obvious cause. These patients were scheduled for MR imaging to evaluate endolymphatic hydrops between April and October 2012 at a tertiary referral center. Experienced otorhinolaryngologists determined indication for MR imaging based on the presence of ear symptoms, vertigo, average hearing level on pure tone audiometry, results of various otological tests, and clinical history. Table 1 summarizes patient characteristics and symptoms.
All patients underwent MR scanning 4 hours after single-dose (0.2 mL/kg or 0.1 mmol/kg body weight) IV administration of gadolinium-diethylene-triamine pentaacetic acid-bis (methylamide) (gadodiamide: Gd-DTPA-BMA; Omniscan, Daiichi-Sankyo Co. Ltd., Tokyo, Japan) to evaluate the degree of endolymphatic hydrops. The estimated glomerularˆltration rate (eGFR) of all patients exceeded 60 mL/min/1.73 m 2 .
MR imaging
All MR imaging was performed on a 3.0-tesla unit (MAGNETOM  Verio, Siemens, Erlangen, Germany) using a 32-channel array head coil. All patients underwent heavily T 2 -weighted MRC for anatomical reference of total lymph ‰uid, hT 2 W-3D-FLAIR with inversion time of 2250 ms (PPI), and hT 2 W-3D-IR with inversion time of 2050 ms (PEI) according to the clinical protocol of our hospital for evaluating endolymphatic hydrops. Parameters were set as previously reported. 13 Detailed scan parameters for MRC follow.
For variable ‰ip angle 3D-turbo spin-echo (SPACE: sampling perfection with application-optimized contrasts by using diŠerent ‰ip angle evolutions), parameters were: repetition time (TR), 4400 ms; echo time (TE), 544 ms; initial refocusing 1809 ‰ip angle rapidly decreased to constant 1209‰ip angle for the turbo spin-echo refocusing echo train; echo train length, 173 with restore magnetization pulse (fast recovery pulse); matrix size, 322×384; 104 axial slices with 1.0-mm-thick covering the labyrinth;ˆeld of view (FOV), 15×18 cm; generalized autocalibrating partially parallel acquisition (GRAPPA) parallel imaging technique; acceleration factor, 2; number of excitations (NEX), 1.8; and scan time, 3 min.
Scan parameters of hT 2 W-3D-FLAIR for PPI were similar to those of MRC except for the application of an inversion pulse with inversion time of 2250 ms; TR, 9000 ms; NEX, 4; and scan time, 15 min. Shorter inversion time was employed for PEI (2050 ms) than PPI (2250 ms). Scan time of PEI and PPI were the same. PPI and PEI did not utilize restore pulse. MRC, PPI, and PEI employed identical FOV, matrix size, and slice thickness to facilitate comparison.
Image processing
We generated HYDROPS and HYDROPS2 images on the scanner console. HYDROPS images were generated by subtracting the PEI from the PPI. Because signal intensity values of perilymph are usually far larger on MRC without an inversion pulse than on PPI with an inversion pulse, we generated HYDROPS2 images by subtracting the MRC multiplied by 0.05 from the PPI based on our previous study. 14 For the result of subtraction, negative signal value was allowed for both HYDROPS and HYDROPS2. Acquisition of source images takes 30 min for HYDROPS images and 18 min for HYDROPS2 images. In this study, we applied no image motion registration program during subtraction. For the HYDROPS and HYDROPS2 images, a neuroradiologist subjectively conˆrmed the absence of misregistration artifact, i.e., apparent double contour of the labyrinth.
HYDROPS, HYDROPS2, and MRC images were transferred by CD-ROM to an iMac personal computer (Apple Computer, Inc., Cupertino, CA, USA) with a free DICOM viewer (OsiriX image software, ver. 3.0.2. 32 bit; downloadable at http:// www.osirix-viewer.com/index.html), which allowed easy pixel-by-pixel multiplication between the image series in a few seconds. The HYDROPSMi2 image (Image #1) was obtained by multiplying the MRC and HYDROPS images. The HYDRO-PS2-Mi2 image (Image #2) was obtained by multiplying the MRC and HYDROPS2 images. Figure  1 is a conceptual diagram of the image processing. The aim of multiplying the MRC image onto the HYDROPS and HYDROPS2 images was to set to zero the signal intensity value of bony structures possibly included in the region of interest (ROI), i.e., osseous spiral lamina, interscalar septum and bony wall of the labyrinth. Without multiplication, such bony structures might show non-zero negative signal intensity values due to the low signal-to-noise ratio (SNR) of the HYDROPS and HYDROPS2 images, which would result in overestimation of the size of the area of endolymph.
Image analysis
Three radiologists, with 24 years' experience in neuroradiology and 3 and 2 years' experience in radiology, independently evaluated the images. Each observer manually contoured the cochlea and vestibule separately to set up an ROI on the MRC after receiving the following instructions:`B efore starting the contouring of the cochlea or vestibule on MRC, set the image window level and width to 400/1000.`F or the cochlear ROI, select the slice on which the cochlear modiolus is visually largest. If the size of the modiolus is comparable on 2 or more slices, choose the slice with the largest height of the modiolus. When contouring the cochlea on MRC, exclude the modiolus when drawing the ROI.`F or the vestibular ROI, select the lowest slice where the lateral semicircular canal ring is visualized more than 2409 , and exclude the semicircular canal and ampulla when drawing the ROI for the vestibule on MRC.'' Reviewers were also shown an example of ROI setting before starting the contouring (Fig. 2) . The ROI of the cochlear slice was deˆned to select the middle part of the cochlea, and the ROI of the vestibular slice, to select the middle of the vestibule. These ROIs drawn on MRC were copied and pasted onto Images #1 and #2. We then used the histogram function of OsiriX to measure the numbers of all pixels in the ROI and the numbers of pixels with negative signal intensity values (i.e., endolymph) in the ROI.
The ratio of the area (z) of endolymphatic space in the entire lymphatic space (zEL) was deˆned as: zEL＝(number of negative pixels for the endolymph in the ROI divided by the total number of pixels in the ROI)×100.
Statistical analysis
We investigated the relationship between the zEL in Images #1 and #2 by linear regression analysis and evaluated interobserver and image type diŠerence in the zEL using analysis of variance (ANOVA) for a 2×3 repeated-measures design on the zEL for 48 ears. Factors were the 2 types of generated images (Images #1 and #2) and 3 observers. If the null hypothesis in Mauchly's test of sphericity was rejected, the adjustments to degrees of freedom of the F test statistics were done using the Greenhouse-Geisser epsilon, Huynh-Feldt epsilon, and lower-bound epsilon.
We used SPSS 17 software (SPSS Inc., Chicago, Illinois, USA) for all statistical analyses and adopted 5z as the signiˆcance level for statistical testing.
The medical ethics committee of our institution approved this retrospective study, and informed consent was waived.
Results
No misregistration artifact from motion was noted in any ear. Table 2 shows the mean zEL of the cochlea and vestibule on Images #1 and #2 for the 3 observers. Figure 3a shows the relationship between the zEL in the 2 types of generated images for the cochlea, and Fig. 3b shows that for the vestibule. A strong linear correlation was observed between the zEL in the 2 types of generated images for each observer; the Pearson's correlation coe‹cients (r) were 0.783, 0.734, and 0.800 for the cochlea and 0.924, 0.930, and 0.933 for the vestibule (Pº0.001, for all). Further, the linear regression lines for the 3 observers were almost identical. All the linear regression lines intersected the vertical axis at positive values of zEL on Image #2 and at the 0z of zEL on Image #1.
For both the cochlea and vestibule, repeatedmeasures ANOVA showed signiˆcant diŠerence between the area ratio means in the 2 types of generated images (Pº0.001). However, the diŠerence among observers was not signiˆcant (P＝0.235 for Greenhouse-Geisser epsilon, 0.234 for HuynhFeldt epsilon, 0.230 for lower-bound epsilon in the cochlear image; P＝0.600 for Greenhouse-Geisser epsilon, 0.607 for Huynh-Feldt epsilon, 0.488 for lower-bound epsilon in the vestibular image), and there was no statistically signiˆcant interaction be- 
Discussion
For both the cochlea and vestibule, we observed no signiˆcant diŠerence among the 3 observers for both Images #1 and #2. Correlation between the 2 images was also strong in the cochlea and vestibule for each observer, although the diŠerence between the images was signiˆcant. This is theˆrst report to assess endolymph size quantitatively by IV-SD-GBCM, and there was little interobserver variability. This consistency may be attributable to the fact that the setting of the ROI on MRC was the only observer-dependent part, and it was precisely detailed.
The linear regression lines intersected the vertical axis at positive values of zEL of Image #2, where many datapoints of Image #1 showed 0z of ELz in the cochlea and vestibule (Fig. 3) . In the previously reported MR imaging study obtained after IT administration of GBCM, the normal values of zEL were 8 to 26z in the cochlea and 20 to 41z in the vestibule. 18 In the previous histological study, the zEL in control subjects was 9 to 12z in the cochlea and 22 to 26z in the vestibule. 19 These results suggest that there should be some non-zero zEL values even in healthy condition. Therefore, we can speculate that Image #1 tends to underestimate the values of zEL, probably as a result of the blurring eŠect of small endolymph on PEI. 10 A subjective 3-step scale was introduced to grade endolymphatic hydrops in both the cochlea and vestibule on MR images. 17 Then, a 4-step scale 16 was proposed based on the 3-step scale. However, neither grading system speciˆes the slice level to use for evaluation or deˆnes how to manage cases with nonuniform distribution of endolymphatic hydrops in each cochlear turn.
A quantitative method is proposed to measure endolymph size manually on 3D-FLAIR images obtained after IT administration of GBCM. 18 In this method, the cochlear ducts in each cochlear turn are manually traced on a 3D-FLAIR image at the mid-modiolar level. However, borders between the cochlear endolymph and surrounding bone are unclear on 3D-FLAIR, so the manual tracing of the area of endolymph is susceptible to observer bias. Contouring cochlear ducts in each turn is also timeconsuming. Another study proposed a grading method in which the labyrinth was segmented into 7 parts, the presence of contrast enhancement of perilymph on 3D-FLAIR obtained after IT administration of GBCM was noted for each part, and the parts showing enhancement were counted. 20 The points correlated well with patient symptoms, and interobserver variability was small. However, endolymphatic size cannot be directly evaluated by counting the number of parts with perilymph enhancement after IT administration of GBCM. Absence of enhancement in perilymph does not neces-sarily indicate the presence of endolymphatic hydrops. Distribution of GBCM in the perilymph might be impaired due to poor penetration of the round window membrane. 21 Furthermore, less uniform distribution of GBCM in the cochlea by IT than IV administration is reported. 22 Just counting the number of sites with perilymphatic enhancement after IT administration of GBCM might not be su‹ciently robust as an evaluation method for endolymphatic hydrops. The method proposed in the present study allowed the separate and simultaneous direct measurement of the zEL of the cochlea and vestibule in the ears of both sides, was less invasive, and showed little interobserver variability.
Our study is limited because we included no healthy subjects and no patients with deˆnite M áenieà re's disease. However, the wide variety of zEL either in the cochlea or vestibule enabled us to fulˆll our study purposes. Evaluation was performed by the area ratio of endolymph in the total lymph in a slice and not by the volume ratio of endolymph in the total lymph volume. Volume might be evaluated by measuring the area on all slices, but this is quite time-consuming. In the present study, we chose a practical and clinically applicable method. No histological conˆrmation regarding the size of endolymphatic space was obtained, so we cannotˆrmly decide whether Image #1 or #2 provided better results compared to the truth. Neither can we rule out the possibility that the multiplication of MRC might have altered the shape of the endolymphatic space. It is virtually impossible to obtain histological specimens in benign conditions like endolymphatic hydrops. The present study suggested the possibility of slight underestimation of Image #1. Further study comparing the zEL on MR images, patient symptoms, and otological tests would be necessary in a larger number of patients to establish the quantitative assessment of endolymphatic hydrops on MR.
Although we noted no signiˆcant motion, motion could also cause image misregistration. However, reducing scan time from 33 min for Image #1 to 18 min for Image #2 should reduce the chance of signiˆcant motion.
Conclusions
HYDROPS-Mi2 (Images #1) and HYDROPS2-Mi2 (Images #2) might enable semi-quantiˆcation of endolymphatic size with small observer dependency even by less invasive IV-SD-GBCM. Correlation of Images #1 and #2 was strong, but Image #1 seemed to underestimate the zEL more than Image #2.
